Intravitreal Injection of Triamcinolone Acetonoide Versus ANTI-VEGF for treatment of retinal vascular diseases
Amr Mohammed Yaseen;
Abstract
Triamcinolone has been shown to inhibit the expression of the vascular endothelial growth factor (VEGF), in addition to anti-inflammatory properties, anti-permeability function, and neuroprotective effects; Anti-VEGF agents, such as bevacizumab, ex
Other data
| Title | Intravitreal Injection of Triamcinolone Acetonoide Versus ANTI-VEGF for treatment of retinal vascular diseases | Other Titles | مقارنة بين تأثير حقن مادة الترايمسينولون أسيتونويد وحقن المواد المضادة لعوامل نمو بطانة الأوعية الدموية لعلاج أمراض الأوعية الدموية في شبكية العين | Authors | Amr Mohammed Yaseen | Keywords | Intravitreal Injection of Triamcinolone Acetonoide Versus ANTI-VEGF for treatment of retinal vascular diseases | Issue Date | 2012 | Description | Triamcinolone has been shown to inhibit the expression of the vascular endothelial growth factor (VEGF), in addition to anti-inflammatory properties, anti-permeability function, and neuroprotective effects; Anti-VEGF agents, such as bevacizumab, ex |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.